Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troussard

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
Journal of Hematology & Oncology|February 25, 2021
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trialRobert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.
Cancer Medicine|January 30, 2023
Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in FranceKueshivi Midodji Atsou, Bernard Rachet, Edouard Cornet, et al.
Leukemia & Lymphoma|June 1, 2017
Increased frequencies of circulating and tumor-resident Vδ1<sup>+</sup> T cells in patients with diffuse large B-cell lymphomaEmilie Reboursiere, Anne-Claire Gac, Anthony Garnier, et al.
The Journal of Biological Chemistry|August 1, 2000
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathwaysM D'Amico, J Hulit, D F Amanatullah, et al.
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Perls' Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC)Camille Lours, Laurane Cottin, Margaux Wiber, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2025
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based studyA Trama, E E Geerdes, E Demuru, et al.
Clinical Case Reports|May 19, 2023
Hairy cell leukemia with isolated bone lesionsLaura Cailly, Cécile Gruchet, Elsa Maitre, et al.
Pediatric Blood & Cancer|May 18, 2018
Adolescent and young adult oncology patients in France: Heterogeneity in pathways of careEmmanuel Desandes, Laurence Brugières, Florence Molinié, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3)N Ssenyonga, C A Stiller, R Marcos-Gragera, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Journal of Hematology & Oncology|February 25, 2021
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trialRobert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.
Cancer Medicine|January 30, 2023
Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in FranceKueshivi Midodji Atsou, Bernard Rachet, Edouard Cornet, et al.
Leukemia & Lymphoma|June 1, 2017
Increased frequencies of circulating and tumor-resident Vδ1<sup>+</sup> T cells in patients with diffuse large B-cell lymphomaEmilie Reboursiere, Anne-Claire Gac, Anthony Garnier, et al.
The Journal of Biological Chemistry|August 1, 2000
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathwaysM D'Amico, J Hulit, D F Amanatullah, et al.
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Perls' Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC)Camille Lours, Laurane Cottin, Margaux Wiber, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2025
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based studyA Trama, E E Geerdes, E Demuru, et al.
Clinical Case Reports|May 19, 2023
Hairy cell leukemia with isolated bone lesionsLaura Cailly, Cécile Gruchet, Elsa Maitre, et al.
Pediatric Blood & Cancer|May 18, 2018
Adolescent and young adult oncology patients in France: Heterogeneity in pathways of careEmmanuel Desandes, Laurence Brugières, Florence Molinié, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3)N Ssenyonga, C A Stiller, R Marcos-Gragera, et al.
Pageof 37